Clinical Trial Update: Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating intranasal glucagon for children and adolescents with Type 1 diabetes has completed Phase 2/3 trials with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• intranasal glucagon (glucagon)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-03-06